782 related articles for article (PubMed ID: 32866942)
1. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
2. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
[TBL] [Abstract][Full Text] [Related]
3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
4. Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children.
Buonsenso D; Delogu G; Del Carmen Pereyra Boza M; De Maio F; Palucci I; Martino L; Pata D; Sanguinetti M; Valentini P; Sali M
Eur J Pediatr; 2023 May; 182(5):2155-2167. PubMed ID: 36847873
[TBL] [Abstract][Full Text] [Related]
5. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
Tsuyuzaki M; Igari H; Okada N; Suzuki K
J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
[TBL] [Abstract][Full Text] [Related]
9. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
[TBL] [Abstract][Full Text] [Related]
10. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
Allen NP; Swarbrick G; Cansler M; Null M; Salim H; Miyamasu M; Howard J; Boyle J; Lewinsohn D; Lewinsohn D
Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508
[TBL] [Abstract][Full Text] [Related]
11. CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.
Lee MR; Chang CH; Chang LY; Chuang YC; Sun HY; Wang JT; Wang JY
J Infect; 2019 Apr; 78(4):299-304. PubMed ID: 30707912
[TBL] [Abstract][Full Text] [Related]
12. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment.
Chiacchio T; Petruccioli E; Pepponi I; Vanini V; Gualano G; Cirillo D; Palmieri F; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S141-S142. PubMed ID: 28043513
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
[TBL] [Abstract][Full Text] [Related]
15. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
[TBL] [Abstract][Full Text] [Related]
16. A multicentre verification study of the QuantiFERON
Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
Tang J; Huang Y; Cai Z; Ma Y
PLoS One; 2021; 16(7):e0254571. PubMed ID: 34270559
[TBL] [Abstract][Full Text] [Related]
18. Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study.
Chedid C; Kokhreidze E; Tukvadze N; Banu S; Uddin MKM; Biswas S; Russomando G; Acosta CCD; Arenas R; Ranaivomanana PP; Razafimahatratra C; Herindrainy P; Rakotonirina J; Raherinandrasana AH; Rakotosamimanana N; Hamze M; Ismail MB; Bayaa R; Berland JL; De Maio F; Delogu G; Endtz H; Ader F; Goletti D; Hoffmann J
Front Immunol; 2020; 11():616450. PubMed ID: 33603746
[TBL] [Abstract][Full Text] [Related]
19. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
[TBL] [Abstract][Full Text] [Related]
20. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
